ClinicalTrialsFinder

HER2-positive Metastatic Breast Cancer Clinical Trials in Anderlecht, Brussels Capital

1 recruitingAnderlecht, Brussels Capital, Belgium

Showing 1–1 of 1 trials

Recruiting
Phase 2

HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer

HER2-positive Metastatic Breast CancerHER2-positive Advanced Breast Cancer
Jules Bordet Institute87 enrolled1 locationNCT06595563